BZO One Step Benzodiazepines Rapid Test (Oral Fluid)
Rapid lateral flow immunoassay for the qualitative detection of benzodiazepines in oral fluid, used by healthcare professionals to screen for recent sedative exposure. CE Marked.
Product Description
The benzodiazepines test uses a competitive lateral flow format. A solid-phase membrane carries benzodiazepine antibody and the matching drug-protein conjugate, with the antibody coupled to colloidal gold. Applied oral fluid migrates by capillary action and any benzodiazepine present competes with the conjugate for limited antibody binding sites. When enough drug is present it saturates the antibody, the conjugate is not captured at the test line, and the test line disappears — a missing test line is read as positive. In a negative sample a visible test line forms. A colored control line must appear in every valid run, confirming adequate specimen and proper membrane wicking.
Benzodiazepines are medicines commonly prescribed for anxiety and sleep disorders, acting through receptors linked to the neurotransmitter GABA. They are also used as sedatives before medical procedures and in managing seizures and alcohol withdrawal, so a positive screen may reflect legitimate prescribed use as well as misuse. Oral fluid testing indicates recent exposure, but interpretation should consider legitimate medication and clinical history. The test is a preliminary qualitative screen only; it does not measure concentration, timing or impairment. Presumptive positives require laboratory confirmation, and a physician should make the final diagnosis.
Specifications
| Product Name | Cat. No. | Specimen | Cut-off | Format |
|---|---|---|---|---|
| BZO Benzodiazepines | BZO-R02 | Oral Fluid | 50ng/ml | Device |
Send an Inquiry
Tell us the product and quantity you need. We will reply by email with pricing, packaging and availability for the BZO One Step Benzodiazepines Rapid Test (Oral Fluid).